Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mesonephric Gynecologic Cancer 1 Melanoma 1 Lung Neoplasms 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1 Brain Neoplasms 1 Advanced Colorectal Cancer 1 Adenocarcinoma of Lung 1

Interventions

Magnetic Resonance Spectroscopy 23 Radiosurgery 21 Temozolomide 14 Bevacizumab 11 pembrolizumab 10 Specimen Handling 9 Nivolumab 8 Radiotherapy 7 Ipilimumab 7 Magnetic Resonance Imaging 6 Cyclophosphamide 5 Capecitabine 5 Blood Specimen Collection 5 encorafenib 4 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Memantine 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 binimetinib 3 abemaciclib 3 Watchful Waiting 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × defactinib × Clear all

NCT06194929 2025-12-03

DETERMINE

University of Utah

Phase 1/2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡